AmerisourceBergen PF Latex SG (Surgical Glove), Sterile, Powder Free, Size 6.5, Item No. 10112
WRP Asia Pacific Sdn Bhd began a recall of AmerisourceBergen PF Latex SG (Surgical Glove), Sterile, Powder Free, Size 6.5, Item No. 10112 on . FDA classified it as Class II and gives the reason as "Some left-handed gloves contain powder. Powdered surgical gloves are a banned medical device in the U.S. Powder on natural rubber latex gloves can aerosolize latex allergens, resulting in sensitization to latex and...". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.
Recall record
- Recall number
- Z-2036-2018
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- WRP Asia Pacific Sdn Bhd
- Product
- AmerisourceBergen PF Latex SG (Surgical Glove), Sterile, Powder Free, Size 6.5, Item No. 10112
- Product code
- KGO Surgeon'S Gloves
- Reason for recall
- Some left-handed gloves contain powder. Powdered surgical gloves are a banned medical device in the U.S. Powder on natural rubber latex gloves can aerosolize latex allergens, resulting in sensitization to latex and allergic reactions. Additional risks of powdered gloves include severe airway inflammation, conjunctivitis, dyspnea, as well as granuloma and adhesion formation when exposed to internal tissue.
- Root cause tag
- manufacturing process
- FDA root cause
- Process control
- Action
- On May 7, 2018, WRP (contract manufacturer) issued an Urgent Medical Device Recall notice to its affected customer. The customer then notified its U.S. consignee, American Health Packaging, which in turn disseminated the recall information to affected consignees, down to the user level. The following instructions were provided to affected customers: If you are a Distributor: 1. Immediately examine your inventory, quarantine and discontinue distribution of these lots. 2. Carry out a physical count and record this data on the Business Reply Card and the Packing slip, which are included with this letter. Complete the enclosed Business Reply Card even if you do not have any product on hand. 3. Please pass this Recall Notice on ONLY to users that received these product lots. 4. Return the recalled product and the Packing Slip using the prepaid FedEx shipping labels to: GENCO Pharmaceutical Services a subsidiary of FedEx Supply Chain 6101 North 64th Street Milwaukee, WI 53218 If you are a User: 1. Immediately examine your inventory, quarantine and discontinue distribution of these lots. 2. If you have units of the affected products/lots in inventory, please contact GENCO Pharmaceutical Services at 877-319-8964 to receive a recall return packet. If you have not received this product you do not need to request a return packet. 3. Carry out a physical count and record this data on the Business Reply Card and the Packing slip, which are included with this letter. 4. You do not need to contact any patients. 5. Return the recalled product and the Packing Slip using the prepaid FedEx shipping labels to: GENCO Pharmaceutical Services a subsidiary of FedEx Supply Chain 6101 North 64th Street Milwaukee, WI 53218 To receive credit, the reply form and recalled product must be returned to GENCO by August 16th, 2018. For questions about the recall process, call GENCO Pharmaceutical Services at (877) 319-8964.
- Quantity in commerce
- 201,000 pairs
- Distribution
- Distributors in AL, CA, OH, ID, KS, MN, NC, PA, TX.
- Product codes and lots
- Lot 705366565
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-2036-2018 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
